Medical News

The new Ebola vaccine rVSV-EBOV shows promise in preventing the next outbreak of the disease but it comes with side effects. It also only works against one subtype of the hemorrhagic virus.

It's evening on Christmas Eve, and it's cold. The early sunset was hours ago, and the insulating clouds have vanished, leaving every surface frozen and glittering like the inside of a geode wherever the light from the st...

Researchers in Canada have discovered that another factor may be very important in the recovery process of people suffering from traumatic brain injuries - sleep. Their study shows a very clear connection between a patie...

Scuba divers may undergo several medical checks, but one problem still remains ignored. According to a new pilot study, scuba divers are very likely to have dental problems during and after diving, so visiting a dentist ...

A new study may have just found one of the causes of premature aging. The implications are numerous, and scientists are looking into new practical ways of fighting aging.

New research shows that taking breaks from Facebook could positively influence people's well-being. The study found a deterministic causality between not spending time on the social networking website for an entire week ...

A study on mice reveals that improving the vitamin D levels in the body can aid the prevention and treatment of metabolic syndrome, which is the key to chronic diseases like heart problems and diabetes. Vitamin D is also...

Worried about gaining a few extra pounds during the holidays? We've listed down several tips so you can still indulge and eat the meals you want while still keeping yourself healthy.

New recommendations from the American College of Obstetricians and Gynecologists suggest a delay in the clamping of the umbilical cord. The recommendation is issued for both term and preterm infants and it is based on de...

Roche's drug ocrelizumab was found effective against both relapsing multiple sclerosis and primary progressive multiple sclerosis. Using magnetic resonance imaging, researchers found that ocrelizumab was 95 percent more ...